Injective (INJ) Soars Over 5% Toward $6 as Volume Surges and Market Rebounds

  • Injective’s price rose more than 5% in the past 24 hours, reaching an intraday high of $5.85.
  • Bulls could push the price toward $10, but that scenario depends on clearing resistance around $6.
  • INJ is riding broader market momentum and positive developments within its network.

Injective’s native token was among the altcoins that recorded gains on December 8, 2025, climbing more than 5% to a high of $5.85 as investor focus shifted ahead of a major week for risk assets.

The INJ price spiked and approached the $6 level, a zone that acted as recent downside pressure as of December 4.

Notably, Injective’s rally coincided with heightened trading activity and growing market interest.

Injective price climbs toward $6 amid surging volume

Since its all-time high of $52.75 in March 2024, Injective’s price has been in a downtrend. The token is down roughly 89% from that peak and has fallen about 25% over the past month.

Recent market-wide gains have supported bulls, allowing INJ to recover from support near $5.

At the time of writing, INJ is trading around $5.71 after rising more than 5% over the last 24 hours.

The bullish move pushed prices toward the psychological $6 level, with an intraday peak at $5.85. Trading volume also surged to roughly $67 million, up more than 52% in the past day.

What’s driving Injective’s price rise?

Token gains came alongside a broader crypto rebound, with Bitcoin pushing back above $92,000 and Ethereum reclaiming levels above $3,100, which helped lift risk assets across the market.

Analysts also pointed to Injective’s recent integration with DexTools, exposing the chain to an estimated 15 million users who use the platform for real-time asset monitoring. That exposure likely contributed to the uptick in interest.

Momentum also appears to be coming from Helix, a leading decentralized spot and derivatives exchange within the INJ ecosystem. Helix recently rolled out upgrades to its DeFi app that enable gasless, 24/7 trading of stocks, indices and cryptocurrencies.

🌐 Trade RWAs on @HelixMarkets

Stocks, pre-IPO markets, commodities, FX — all tradable on-chain.

📊 Live markets:
$AAPL, $NVDA, $AMZN, $SpaceX, $TSLA, Gold and more! pic.twitter.com/ErlY5ZVXd3

— Helix 🧬 (@HelixMarkets) December 5, 2025

The community has also responded positively to on-chain governance proposals and approvals related to stock price feeds. Additionally, stablecoin deployments and initiatives focused on real-world assets (RWAs) appear to be contributing to momentum across the ecosystem.

INJ price outlook

Although bulls tested $6 with a 24-hour high of $5.85, the technical picture remains mixed. The overall trend is still bearish since the 2024 highs, and continued downward pressure could be damaging for buyers if it persists.

Injective Price Chart
TradingView

by TradingView

The relative strength index (RSI) sits at about 44, below neutral territory.

However, momentum indicators are showing signs of improvement. The RSI has turned upward, suggesting a possible breakout, while the moving average convergence divergence (MACD) shows modest bullish momentum after a recent bullish crossover.

Looking ahead, INJ’s path could split between a bullish breakout and a cautious range-bound recovery.

In the short term, a clear break above $6 would open upside targets near $8.22 and then $10. Conversely, a drop below $5.05 could create a dangerous environment for buyers and risk extending the downtrend.

Traders and investors should monitor volume and key technical levels closely to assess whether the current recovery can sustain itself or if the broader bearish pressures will reassert control.